2025-01-17 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**1. Performance Comparison and Outperformance:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs and related services.  Over the period analyzed, UNH significantly outperformed the S&P 500 (VOO).  The cumulative return for UNH is 136.65%, while VOO's is 116.43%. This represents a difference of 20.2 percentage points.  The relative outperformance, considering the historical range of the difference, is at the 82.6 percentile (17.4 on a 0-100 scale).

**Alpha and Beta Analysis:**

The provided alpha values consistently show positive excess returns relative to the market (Beta of approximately 0.1). However, the CAGR (Compound Annual Growth Rate) and MDD (Maximum Drawdown) values fluctuate considerably across different time periods, indicating periods of both strong growth and significant risk.  The recent years (2022-2025) show negative CAGRs reflecting market downturns impacting even strong performers.  Capitalization (Cap) remains consistently high at approximately $471 billion.


**2. Recent Price Movement:**

* **Closing Price:** $513.05
* **Last Market Price:** $511.73
* **5-day Moving Average:** $532.41
* **20-day Moving Average:** $512.69
* **60-day Moving Average:** $555.65

The stock price is currently trading below its 5-day, 20-day, and 60-day moving averages, suggesting a short-term bearish trend. The last market price is very close to the 20-day average, indicating potential support at this level.


**3. Technical Indicators and Expected Return:**

* **RSI:** 53.89  (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.95 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence Change:** -4.5% (Short-term bearish divergence)

The relatively low RSI and negative recent relative divergence suggest a potential short-term correction. The positive PPO is in conflict with this interpretation, suggesting potential momentum building.  The relatively lower current price compared to the 5-day, 20-day, and 60-day moving averages could be attributed to a slight pullback and is not suggestive of a rapid dramatic decline.  The expected return of 380.5% over the long term (2+ years) relative to the S&P 500 is a significant projection and should be viewed cautiously.  This needs further elaboration on the methodology and assumptions employed.

**4. Recent Earnings Analysis:**

The earnings data shows fluctuating EPS and revenue.  There's a significant drop in EPS in Q2 2024 (-1.53), followed by recovery in Q3 (6.56).  Revenue remains relatively stable, hovering around $98 billion, indicating consistent business activity. The duplication of the November 2024 data point should be clarified.

| Date       | EPS   | Revenue (B$) |
|------------|-------|-------------|
| 2024-11-04 | 6.56  | 100.82       |
| 2024-08-09 | 4.58  | 98.86        |
| 2024-05-09 | -1.53 | 99.80        |
| 2023-11-06 | 6.31  | 92.36        |


**5. Financial Information Analysis:**

Revenue has remained relatively stable, with only minor fluctuations.  Profit margins have generally stayed above 20%, although there has been slight decline since Q3 2023.  Equity has been increasing in general. ROE (Return on Equity) has fluctuated and even became negative in Q1 2024. This suggests some variability in profitability and efficiency.


| Quarter    | Revenue (B$) | Profit Margin (%) | Equity (B$) | ROE (%) |
|------------|-------------|-----------------|-------------|--------|
| 2024-09-30 | 99.18       | 21.56           | 94.53       | 6.41   |
| 2024-06-30 | 97.86       | 21.52           | 89.36       | 4.72   |
| 2024-03-31 | 98.78       | 22.26           | 86.69       | -1.63  |
| 2023-12-31 | 93.25       | 22.33           | 88.76       | 6.15   |
| 2023-09-30 | 91.36       | 24.51           | 84.49       | 6.91   |


**7. Overall Summary:**

UNH has demonstrated strong historical outperformance compared to the S&P 500. However, recent price action shows a short-term bearish trend. While long-term projections are positive, the short-term outlook warrants caution. Fundamental analysis reveals consistent revenue but some volatility in EPS and ROE. The projected long-term return should be considered with caution due to the lack of detail in methodology and market condition uncertainties. Further investigation into the earnings fluctuations and the methodology behind the long-term return projections is recommended before making investment decisions.  The data inconsistencies (duplicate data point) require clarification.
